Defibrillators-a shocking therapy for cardiomyopathy?

Nature Reviews Cardiology

Volumn 7, Issue 2, 2010, Pages 69-70

  Cleland, John G F ^a   Buga, Laszlo ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; DEFIBRILLATOR; DISEASE SEVERITY; HEALTH STATUS; HEART FAILURE; HUMAN; IMPLANTATION; PATIENT SELECTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SHORT SURVEY; CARDIOVERSION; CONGESTIVE CARDIOMYOPATHY; EQUIPMENT; EQUIPMENT DESIGN; HEART PACING; INSTRUMENTATION; MORTALITY; NOTE; RISK ASSESSMENT; SUDDEN DEATH; TREATMENT OUTCOME;

CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, DILATED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EQUIPMENT DESIGN; EQUIPMENT FAILURE; HUMANS; PATIENT SELECTION; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 76449090480     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2009.233     Document Type: Short Survey

References (10)

1. Cleland, J. G. F., nasir, M. & Tageldien, A. Cardiac resynchronization therapy or atriobiventricular pacing-what should it be called? Nat. Clin. Pract. Cardiovasc. Med. 4, 90-101 (2007).
2. Cleland, J. G., Tavazzi, L., Daubert, J. C., Tageldien, A. & Freemantle, n. Cardiac resynchronization therapy. Are modern myths preventing appropriate use? J. Am. Coll. Cardiol. 53, 608-611 (2009).
3. Bardy, G. H. et al. Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure. N. Engl. J. Med. 352, 225-237 (2005).
4. Yao, G. et al. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter- defibrillator. Eur. Heart J. 28, 42-51 (2007).
5. Gasparini, M. et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (iCD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the ReLevAnT [Role of long detection window programming in patients with Left ventriculAr dysfunction, non-ischemic eTiology in primary prevention treated with a biventricular iCD] study. Eur. Heart J. 30, 2758-2767 (2009).
6. Arthur, w. & Kaye, G. C. Clinical use of intracardiac impedance: current applications and future perspectives. Pacing Clin. Electrophysiol. 24, 500-506 (2001).
7. Connolly, s. J. et al. Comparison of betablockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTiC study: a randomized trial. JAMA 295, 165-171 (2006).
8. wathen, M. s. et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast ventricular Tachycardia Reduces shock Therapies (PainFRee Rx ii) trial results. Circulation 110, 2591-2596 (2004).
9. wilkoff, B. L. et al. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter eMPiRiC trial. J. Am. Coll. Cardiol. 48, 330-339 (2006).
10. wilkoff, B. L. et al. strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PRePARe (Primary Prevention Parameters evaluation) study. J. Am. Coll. Cardiol. 52, 541-550 (2008).